Neurocrine Biosciences, Inc. (NBIX) — Hedge Fund Ownership Q1 2026
NBIX
- Neurocrine Biosciences, Inc. (NBIX) is held by 1 of 84 tracked hedge funds, with Dodge & Cox (0.4%) holding the largest stake, indicating limited hedge fund interest relative to peers.
- The biggest decreases in NBIX holdings came from Dodge & Cox (-1%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to Neurocrine Biosciences, Inc. (NBIX) by -1% vs the prior quarter and -1% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Dodge & Cox
|
0.40% | 5.5M | -0.85% | -1.33% | $719.4M | $131.74 | — |
| 1 | Total | — | 5.5M | -0.85% | -1.33% | $719.4M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.